Pieris Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-45.72-0.53
Price/Sales ratio
136.5019.52
Earnings per Share (EPS)
$-0.29$-24.8

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-10.66-5.60-2.57-18.79-5.27-7.71-3.65-5.62-2.46-0.66-1.15-5.27
Price/Sales ratio
19.5826.8610.0513.124.853.954.647.762.970.381.383.95
Price/Book Value ratio
5.832.532.3228.783.533.564.384.802.760.612.013.56
Price/Cash Flow ratio
-20.74-6.19-4.076.66-132.45-3.49-2.96-31.85-1.28-0.30-0.57-132.45
Price/Free Cash Flow ratio
-19.70-5.91-3.916.93-51.08-3.33-2.80-28.34-1.26-0.30-0.56-51.08
Price/Earnings Growth ratio
0.00-0.09-0.070.70-0.201.11-0.083.340.060.01-0.06-0.20
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%100%100%-18.83%-58.68%92.46%89.26%2.35%9.11%-18.83%
Operating Profit Margin
-134.16%-466.62%-390.33%-57.74%-105.94%-58.68%-115.68%-164.97%-167.84%-69.50%-155.86%-58.68%
Pretax Profit Margin
-183.59%-472.54%-388.24%-65.45%-93.00%-55.03%-126.40%-145.57%-128.47%-57.33%-120.02%-55.03%
Net Profit Margin
-183.59%-479.50%-391.02%-69.82%-91.93%-51.33%-126.96%-138.02%-120.65%-57.33%-120.02%-51.33%
Effective Tax Rate
0.00%-1.47%-0.71%-6.66%1.15%6.72%-0.44%5.18%6.08%N/AN/A6.72%
Return on Assets
-45.00%-41.40%-65.02%-16.98%-18.92%-16.83%-35.45%-28.24%-32.72%-63.45%-51.01%-16.83%
Return On Equity
-54.70%-45.16%-90.37%-153.15%-66.99%-46.25%-119.99%-85.44%-111.90%-91.72%-120.65%-46.25%
Return on Capital Employed
-39.24%-43.91%-85.29%-25.11%-33.05%-23.80%-40.93%-50.32%-73.80%-111.20%-107.39%-23.80%
Liquidity Ratios
Current Ratio
5.5811.313.891.962.814.253.41N/AN/AN/A2.004.25
Quick Ratio
5.5811.663.891.962.814.253.412.522.003.241.774.25
Cash ratio
5.2110.483.500.821.552.303.182.321.051.451.052.30
Days of Sales Outstanding
N/AN/A3.56224.5033.8753.5221.2338.4881.874.8752.2433.87
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A0.00N/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A53.5221.2338.4881.874.87N/A53.52
Days of Payables Outstanding
N/AN/AN/AN/AN/A38.5114.011.32K545.3929.44N/A38.51
Cash Conversion Cycle
N/AN/AN/AN/AN/A15.017.21-1.28K-463.52-24.56N/A15.01
Debt Ratios
Debt Ratio
0.05N/AN/AN/AN/AN/AN/AN/AN/AN/A0.70N/A
Debt Equity Ratio
0.07N/AN/AN/AN/AN/AN/AN/AN/AN/A2.41N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.30N/A
Total Debt to Capitalization
0.06N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
-2.71-74.099.80KN/AN/AN/AN/AN/AN/AN/A-168.24N/A
Cash Flow to Debt Ratio
-3.98N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.211.091.389.013.532.743.383.023.411.443.413.41
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.94-4.33-2.461.96-0.03-1.13-1.56-0.24-2.31-1.25-2.41-1.13
Free Cash Flow / Operating Cash Flow Ratio
1.051.041.040.962.591.041.051.121.011.001.021.04
Cash Flow Coverage Ratio
-3.98N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
-3.98N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A